SPR

SPR Therapeutics is a medical device company based in Cleveland, Ohio, founded in 2010. The company focuses on developing non-opioid, non-surgical, minimally invasive solutions for pain management, addressing the opioid crisis with effective alternatives. Their flagship product, the SPRINT® Peripheral Nerve Stimulation (PNS) System, is the only FDA-approved percutaneous PNS system for treating both chronic and acute pain. This system uses thin leads placed under the skin to deliver electrical pulses that stimulate peripheral nerves, altering pain signal transmission. The SPRINT system has been clinically proven to provide significant pain relief for various conditions, including chronic low back pain and post-surgical pain, with many patients experiencing over 50% pain relief during treatment. SPR Therapeutics aims to make the SPRINT system the standard of care in pain management. The company has treated nearly 50,000 patients and continues to innovate and expand its product applications, serving healthcare providers who seek non-opioid options for their patients.

• Employees 360
• Founded 2010
• Annual Revenue $154300000
• Total Funding $216166884